Accessibility for Ontarians with Disabilities Act (AODA) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the AODA Test. Learn with flashcards and multiple choice questions, each question has hints and explanations. Enhance your knowledge and adherence to accessibility standards in Ontario. Get exam-ready with comprehensive preparation!

Practice this question and more.


Which of the following medications is NOT commonly used in the treatment of alcohol abuse?

  1. Disulfiram

  2. Buprenorphine

  3. Acamprosate

  4. Naltrexone

The correct answer is: Buprenorphine

Buprenorphine is primarily used in the treatment of opioid addiction rather than alcohol abuse. It functions as a partial agonist at opioid receptors, helping to manage withdrawal symptoms and cravings for opioids. Although there are some off-label uses for various substances in treating addictions, Buprenorphine's main indication is specifically for opioid dependence, delineating it from the other medications listed, which are more directly targeted at treating alcohol use disorders. Disulfiram, Acamprosate, and Naltrexone are specifically designed to address alcohol dependency. Disulfiram works by causing unpleasant reactions when alcohol is consumed, thus deterring alcohol use. Acamprosate helps to restore the balance of neurotransmitters in the brain and reduce cravings. Naltrexone blocks the pleasurable effects of alcohol, effectively reducing the desire to drink. Therefore, the selection of Buprenorphine highlights its distinct role in the treatment of opioid use, confirming it as the medication not commonly associated with alcohol abuse treatment.